Simplified HIV treatment options effective in major trial
The world‘s first international trial into second-line HIV therapy has shown two simplified treatments are at least as effective as standard of care.
List view / Grid view
The world‘s first international trial into second-line HIV therapy has shown two simplified treatments are at least as effective as standard of care.
Phase 3 trials of Gilead’s fixed-dose (BIC/FTC/TAF) combination for HIV show high tolerability and low resistance